GSK plcGSKNYSE
Loading
Year-over-year operating cash flow growth rate
| Period | Value |
|---|---|
| Q4 2025 | -32.74% |
| Q4 2025 | 44.45% |
| Q2 2025 | 83.06% |
| Q1 2025 | -50.84% |
| Q4 2024 | 8.12% |
| Q3 2024 | 93.53% |
| Q2 2024 | -6.52% |
| Q1 2024 | -67.10% |
| Q4 2023 | 63.59% |
| Q3 2023 | 69.24% |
| Q2 2023 | 2366.04% |
| Q1 2023 | -96.97% |
| Q4 2022 | 20.65% |
| Q3 2022 | -11.29% |
| Q2 2022 | -35.68% |
| Q1 2022 | -45.95% |
| Q4 2021 | 34.22% |
| Q3 2021 | 159.58% |
| Q2 2021 | 307.80% |
| Q1 2021 | -92.85% |
| Q4 2020 | 437.35% |
| Q3 2020 | -68.80% |
| Q2 2020 | 186.01% |
| Q1 2020 | -72.05% |
| Q4 2019 | 37.30% |
| Q3 2019 | 81.07% |
| Q2 2019 | 109.50% |
| Q1 2019 | -83.90% |
| Q4 2018 | 98.31% |
| Q3 2018 | 52.50% |
| Q2 2018 | 57.82% |
| Q1 2018 | -69.92% |
| Q4 2017 | 51.24% |
| Q3 2017 | 88.19% |
| Q2 2017 | -11.89% |
| Q1 2017 | -61.75% |
| Q4 2016 | 69.27% |
| Q3 2016 | 42.96% |
| Q2 2016 | 145.73% |
| Q1 2016 | -66.49% |